First Time Loading...

Camurus AB
STO:CAMX

Watchlist Manager
Camurus AB Logo
Camurus AB
STO:CAMX
Watchlist
Price: 494.8 SEK 2.49% Market Closed
Updated: May 7, 2024
Section:
 

Relative Value

The Relative Value of one CAMX stock under the Base Case scenario is 867.13 SEK. Compared to the current market price of 494.8 SEK, Camurus AB is Undervalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CAMX Relative Value
Base Case
867.13 SEK
Undervaluation 43%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

16
P/S
P/S
Price to Sales
16
vs History
66
vs Industry
11
Median 3Y
15.3
Median 5Y
17
Industry
2.5
Forward
14.4
More Details
63.8
P/E
P/E
Price to Earnings
63.8
vs History
20
vs Industry
6
Median 3Y
37.8
Median 5Y
-15.1
Industry
23.4
Forward
84.4
More Details
45.4
P/OCF
P/OCF
Price to OCF
45.4
vs History
25
vs Industry
9
Median 3Y
30.3
Median 5Y
-11.6
Industry
17.4
More Details
47
P/FCFE
P/FCFE
Price to FCFE
47
vs History
20
vs Industry
13
Median 3Y
-45.6
Median 5Y
-15.4
Industry
23.6
More Details
18.4
P/B
P/B
Price to Book Value
18.4
vs History
6
vs Industry
3
Median 3Y
13.2
Median 5Y
12.2
Industry
2.1
More Details
15.3
EV/S
EV/S
Enterprise Value to Sales
15.3
vs History
66
vs Industry
10
Median 3Y
14.8
Median 5Y
16.3
Industry
2.6
Forward
13.8
More Details
16.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
16.5
vs History
71
vs Industry
12
Median 3Y
16.5
Median 5Y
18.5
Industry
5.2
More Details
48.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
48.2
vs History
25
vs Industry
7
Median 3Y
30.5
Median 5Y
-11.1
Industry
13.7
Forward
68.8
More Details
49.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
49.4
vs History
20
vs Industry
8
Median 3Y
29
Median 5Y
-11.5
Industry
17.2
Forward
71.9
More Details
43.4
EV/OCF
EV/OCF
Enterprise Value to OCF
43.4
vs History
25
vs Industry
10
Median 3Y
28.4
Median 5Y
-10.9
Industry
16.2
More Details
44.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
44.1
vs History
25
vs Industry
12
Median 3Y
28.8
Median 5Y
-10.5
Industry
17.8
More Details
42.6
EV/IC
EV/IC
Enterprise Value to IC
42.6
vs History
6
vs Industry
3
Median 3Y
18.5
Median 5Y
17.2
Industry
2
More Details

Multiples Across Competitors

CAMX Competitors Multiples
Camurus AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Camurus AB
STO:CAMX
27.5B SEK 16 63.8 48.2 49.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
733.8B USD 20.4 119.5 58.5 66.6
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.9 46.8 34.2 37.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
358.4B USD 4.2 9.3 11.5 15
US
Merck & Co Inc
NYSE:MRK
326B USD 5.3 141.4 35.2 57.5
UK
AstraZeneca PLC
LSE:AZN
187.8B GBP 5 37.3 174.3 278.1
CH
Novartis AG
SIX:NOVN
183.4B CHF 4.3 13.6 10 16.5
CH
Roche Holding AG
SIX:ROG
176.5B CHF 3 15.4 8.7 10.4
US
Pfizer Inc
NYSE:PFE
158.6B USD 2.9 -513.2 12.7 20.3
P/E Multiple
Earnings Growth
SE
Camurus AB
STO:CAMX
Average P/E: 55.9
63.8
377%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
119.5
346%
DK
Novo Nordisk A/S
CSE:NOVO B
46.8
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.3
-20%
US
Merck & Co Inc
NYSE:MRK
141.4
7 454%
UK
AstraZeneca PLC
LSE:AZN
37.3
168%
CH
Novartis AG
SIX:NOVN
13.6
15%
CH
Roche Holding AG
SIX:ROG
15.4
26%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -513.2
680%

See Also

Summary
CAMX intrinsic value, competitors valuation, and company profile.
DCF Valuation
CAMX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CAMX stock valuation using valuation multiples.
Wall Street Estimates
CAMX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CAMX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.